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ABSTRACT: Cognitive decline is one of the earliest hallmarks of
both normal and pathological brain aging. Here we used Ercc1 mutant
mice, which are impaired in multiple DNA repair systems and
consequently show accelerated aging and progressive memory
deficits, to identify changes in the levels of hippocampal synaptic
proteins that potentially underlie these age-dependent deficits. Aged
Ercc1 mutant mice show normal gross hippocampal dendritic
morphology and synapse numbers, and Ercc1 mutant hippocampal
neurons displayed normal outgrowth and synapse formation in vitro.
However, using isobaric tag for relative and absolute quantification
(iTRAQ) of hippocampal synaptic proteins at two different ages,
postnatal days 28 and 112, we observed a progressive decrease in
synaptic ionotropic glutamate receptor levels and increased levels of G-proteins and of cell adhesion proteins. These together
may cause long-term changes in synapse function. In addition, we observed a downregulation of mitochondrial proteins and
concomitant upregulation of Na,K-ATPase subunits, which might compensate for reduced mitochondrial activity. Thus, our
findings show that under conditions of apparent intact neuronal connectivity, levels of specific synaptic proteins are already
affected during the early stages of DNA damage-induced aging, which might contribute to age-dependent cognitive decline.
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■ INTRODUCTION
Impaired memory function is one of the earliest cognitive signs
of both normal and pathological brain aging. This decline can
be partly explained by early changes in synaptic transmission
and/or plasticity, especially in brain areas related to learning
and memory, such as the hippocampus. Neuronal and synaptic
dysfunction precede age-related synapse loss and neuronal
degeneration and occur long before, or even in the absence of,
cell death in humans1 as well as in animals.2−4 Moreover, in
aged animals subtle changes in synaptic function appear to
contribute to alterations in plasticity.5 How synaptic
dysfunction disrupts neuronal network dynamics of aged
neurons and ultimately leads to behavioral deficits and
cognitive decline is still unknown. Molecular and functional
analysis of aging synapses may therefore provide important
clues as to how age-related cognitive decline is triggered and
how it may eventually be treated.
DNA damage plays an important role in aging.6 Unrepaired
DNA damage triggers a complex DNA damage response and
may give rise to epigenetic changes,7 gene silencing, and
specific changes in gene expression.8,9 In addition, persistent
DNA injury may interfere with transcription and/or replication,
triggering cell dysfunction, cell death, or permanent cell cycle
arrest. These processes are considered to be important
causative factors in aging. This is reflected in rare inherited
disorders named segmental progeroid syndromes, in which
genome maintenance is compromised and many features of
aging are accelerated.10−12 Natural aging is however highly
variable in its onset and progression, and genetically modified
mice in which DNA damage is induced or DNA repair is
impaired are therefore attractive models to study the biology of
aging.13 Here, we use Ercc1 mutant mice, which have a
defective DNA repair mechanism and, as a consequence of
unrepaired DNA damage, have a progeroid phenotype. Ercc1
forms a complex with the xeroderma pigmentosum group F
protein (XPF) and acts as nuclease in the nucleotide excision
repair (NER) pathway.14 In addition, it is also involved in
interstrand cross-link repair and double-strand break (DSB)
repair.15−19 Ercc1 knockout (Ercc1−/−) mice develop a severe
and accelerated aging phenotype, including early cessation of
growth, ataxia, and cachexia, and die prematurely at an age of
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3−8 weeks.20−22 Ercc1Δ/− mice on the other hand have a
knockout mutation in one allele of the Ercc1 gene and a
premature stop codon in the other allele, resulting in a
truncated Ercc1 protein, which lacks the last 7 amino acids.21
Therefore, Ercc1Δ/− mice have a milder phenotype compared to
Ercc1−/− mice and die at an age of 4−6 months. They display
many signs of accelerated aging, including motor neuron
degeneration,23 changes in metabolism,24 and age-dependent
impairments in synaptic plasticity and learning behavior.25
Here we took advantage of the highly predictive accelerated
aging pattern observed in Ercc1 mutant mice in order to
robustly identify DNA damage-induced age-related changes in
hippocampal synaptic protein composition that may be difficult
to detect under normal aging conditions. After having
established that Ercc1 mutant mice have no apparent features
of affected hippocampal neuronal connectivity, including
synapse numbers, we used direct approaches to quantitatively
address the synaptic proteome. Specifically, we assessed
biochemically enriched synaptosome fractions and performed
proteomic analyses using isobaric tag for relative and absolute
quantfication (iTRAQ) followed by tandem mass spectrometry.
This approach identified proteins whose levels are altered in 4-
and 16-week-old Ercc1 mutant mice and are discussed in the
context of age-related cognitive decline.
■ EXPERIMENTAL SECTION
Ercc1 Mutant Mice
The generation of Ercc1−/− and Ercc1Δ/− alleles has been
previously described.21 Ercc1Δ/− mice were obtained by
crossing Ercc1+/− with Ercc1Δ/+ mice of C57Bl6J and FVB
backgrounds, respectively, and vice versa, to yield Ercc1Δ/− with
an F1 C57Bl6J/FVB hybrid background. Ercc1−/− mice were
obtained by crossing Ercc1+/− with Ercc1+/− mice of C57Bl6J
and FVB backgrounds to yield Ercc1−/− with an F1 C57Bl6J/
FVB hybrid background. Wildtype littermates were used as
controls. Breeding was performed in accordance with the
Principles of Laboratory Animal Care (NIH publication no. 86-
23) and with the guidelines approved by the Erasmus
University Animal Care Committee. All animal experiments
were approved by the Animal Users Care Committee of the VU
University Amsterdam (protocol MCN 08-06).
Primary Hippocampal Cultures
Hippocampi were dissected from E18 Ercc1−/−, Ercc1Δ/−, and
wildtype embryos and collected in Hanks balanced salts
solution (HBSS; Sigma-Aldrich, St. Louis, MO), buffered
with 7 mM HEPES (Invitrogen, Carlsbad, CA, USA).
Hippocampi were incubated for 30 min in HBBS containing
0.25% trypsin (Invitrogen) at 37 °C. After washing, neurons
were triturated using fire-polished Pasteur pipettes, counted,
and plated in Neurobasal medium supplemented with 2% B-27,
1.8% HEPES, 1% glutamax, 1% Pen Strep (all from Invitrogen)
and 0.2% 14.3 mM β-mercapto-ethanol. Cells were plated in
96-well plates (Cellstar, Greiner Bio-One, Frickenhausen,
Germany) that were previously coated with poly-D-lysine
(Sigma-Aldrich) and 5% heat-inactivated horse serum (In-
vitrogen). Neurons were plated at a seeding density of 830
cells/mm2 and cultured at 37 °C/5% CO2 for up to 15 days.
Half of the medium was replaced with fresh medium every
week.
Immunofluorescence and High-Content Screening
Neurons were fixed for 12 min using 4% paraformaldehyde and
4% saccharose in PBS (pH 7.4), washed with PBS,
permeabilized with 0.25% Triton X-100 in PBS for 4 min,
and blocked for 1 h in 1% BSA in PBS. Neurons were stained
with chicken anti-MAP2 (Abcam, Cambridge, U.K.; 1:5,000)
and anti-Synapsin I (Millipore, Billerica, MA, USA; 1:1,000)
overnight at 4 °C. Antigens were visualized using Alexa Fluor
488 and 568 (Invitrogen; 1:400) incubated for 2 h at room
temperature. Neurite outgrowth and synapse formation were
quantified using a Cellomics ArrayScan HCS Reader and the
Cellomics Neuronal Profiling 3.5 bioapplication (Thermo
Scientific, Pittsburgh, PA, USA). In these experiments,
Ercc1−/− (n = 6) and wildtype (n = 6) neurons were used,
and per experiment 400−1,200 cells were analyzed and neuron
counts, neurite lengths, and synapse numbers were determined.
Significance was calculated using univariate analyses of variance
(ANOVA).
Immunohisotchemistry
Mice were intracardially perfused with ice-cold paraformalde-
hyde (4% PFA in PBS, pH 7.4). Brains were removed,
postfixed, embedded in paraffin, microtome-sectioned at 6 μm,
and stained with anti-MAP2 (Millipore; 1:2,000). As secondary
antibody Dylight 549 (Jackson ImmunoResearch, West Grove,
PA, USA; 1:400) was used. Confocal microscopy was
performed using a Carl Zeiss LSM 510 (Zeiss, Germany) at
40x magnification.
Golgi-Cox Staining
Ercc1Δ/− (n = 3) and wildtype (n = 3) mice were intracardially
perfused with ice-cold paraformaldehyde (4% in PBS, pH 7.4).
Brains were removed, postfixed and Golgi-Cox staining was
performed using the FD Rapid GolgiStain Kit (FD Neuro-
Technologies, Ellicott City, MD, USA). After staining, brains
were microtome-sectioned at 100 μm. Neurons were photo-
graphed using a Carl Zeiss LSM 510 meta laser scanner at 63x
magnification and Z-stacks were generated using Carl Zeiss
LSM Image Browser 4.2 software. Z-stacks were used in ImageJ
1.44 g software (NIH, Bethesda, MD, USA) for synapse
counting and dendrite length measurements. To keep the
counting procedure consistent, we only counted spines of
which the spine heads clearly protruded laterally from the
dendritic shafts. Spine densities were calculated by dividing the
total number of spines by the total dendritic length.
Synaptosome Isolation and Sample Preparation
Hippocampi were dissected, frozen, and stored at −80 °C until
protein isolation. Synaptosomes were isolated from hippocampi
of Ercc1Δ/− mice and wildtype littermates at two different ages,
4 weeks (P28) and 16 weeks (P112), as described
previously26,27 with minor modifications. Eight animals were
used per genotype per time point. In order to obtain sufficient
amounts of protein, hippocampi of two mice were pooled,
resulting in four biological replicates per genotype per time
point (n = 4 per genotype, per time point). In brief, pooled
samples were homogenized in ice-cold 0.32 M sucrose buffer
with 5 mM HEPES at pH 7.4 and protease inhibitor (Roche)
and centrifuged at 1000 × g for 10 min at 4 °C to remove
debris. Supernatant was loaded on top of a discontinuous
sucrose gradient consisting of 0.85 and 1.2 M sucrose. After
ultracentrifugation at 110,000 × g for 2 h at 4 °C, the
synaptosome fraction was collected at the interface of 0.85 and
1.2 M sucrose, resuspended, and pelleted by ultracentrifugation
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at 80,000 × g for 30 min at 4 °C, after which the material was
redissolved in 5 mM HEPES. Protein concentrations were
determined using a Bradford assay (Bio-Rad, Hercules, CA,
USA). For each sample, 75 μg of protein was transferred to a
fresh tube and dried in a SpeedVac overnight.
Protein Digestion and iTRAQ Labeling
Per sample, 75 μg synaptosome proteins were dissolved in
0.85% RapiGest (Waters Associates, Milford, MA, USA),
alkylated with methyl methanethiosulfonate, and digested
with trypsin (sequencing grade; Promega, Madison, WI,
USA) as described.27,28 In each iTRAQ experiment, four
wildtype samples were labeled respectively with iTRAQ
reagents 113−116, and four Ercc1Δ/− samples with iTRAQ
reagents 117−119 and 121. To accommodate four biological
replicates in each experiment (P28 and P112), a total of two 8-
plex iTRAQ experiments was performed (Supplemental Figure
S1).
Two-dimensional liquid chromatography (2DLC)
The lyophilized iTRAQ labeled samples were separated in the
first dimension by strong cation exchange column (2.1 × 150
mm polysulfethyl A column, PolyLC), and the in second
dimension on an analytical capillary reverse phase C18 column
(150 mm × 100 μm i.d. column) at 400 nL/min using the LC-
Packing Ultimate system. The peptides were separated using a
linear increase in concentration of acetonitrile from 4% to 28%
in 75 min, to 36% in 7 min, and finally to 72% in 2 min. The
eluent was mixed with matrix (7 mg of recrystallized α-cyano-
hydroxycinnaminic acid in 1 mL of 50% acetronitrile, 0.1%
trifluoroacetic acid, 10 mM ammonium dicitrate) and delivered
at a flow rate of 1.5 μL/min and deposited onto an Applied
Biosystems matrix-assisted laser desorption ionization plated by
means of a robot (Probot, Dionex) once every 15 s for a total
of 384 spots.
MALDI MS/MS
Samples were analyzed on an ABI 4800 proteomics analyzer
(Applied Biosystems, Forster City, CA). Peptide collision-
induced dissociation was performed at 2 kV, and the collision
gas was air. MS/MS spectra were collected from 2500 laser
shots. Peptides with signal-to-noise ratios over 50 at the MS
mode were selected for MS/MS analysis, at a maximum of 30
MS/MS per spot. The precursor mass window was set to a
relative resolution of 200. Peaklists were extracted from the
instrument database using TS2Mascot software (MatrixS-
cience).
Protein Identification
Protein identification and quantification are described in detail
in ref 29. To annotate spectra, Mascot (MatrixScience) searches
were performed against the Swissprot database (release January
2009; 16,028 mouse entries) and against the larger but more
redundant NCBI database (release January 2009; 140,210
mouse entries) using the GPS Explorer software (version 3.6,
Applied Biosystems). MS/MS spectra were searched with
trypsin specificity and fixed iTRAQ modifications on lysine
residues and N-termini of the peptides and methylthio
modifications on cysteine residues. Oxidation on methionine
residues was allowed as a variable modification. Mass tolerance
was 150 ppm for precursor ions and 0.5 Da for fragment ions,
while allowing a single site of miscleavage. The false discovery
rate (FDR) for peptides identification was calculated using a
randomized database (P28: 0.028 and 0.025; P112: 0.027 and
0.027 for NCBI and SwissProt respectively). Protein
redundancy in the result files was removed by clustering the
precursor protein sequences at a threshold of 90% sequence
similarity over 85% of the sequence length. Subsequently all
peptides were matched against the protein clusters and only
those peptides were included that mapped unique to one
protein. Proteins were considered for quantification if at least
three unique peptide had a confidence interval of ≥95%, and at
least three peptides were identified in both experiments (P28
and P112; stringent selection criteria), or at least three peptides
were identified in one experiment and at least one peptide in
the other (relaxed selection criteria).
Protein Quantification and Identification of Differentially
Expressed Proteins
iTRAQ areas (m/z 113−121) were extracted from raw spectra
and corrected for isotopic overlap using GPS explorer. Peptides
with iTRAQ signature peaks of less than 1500 were not
considered for quantification. To compensate for the possible
variations in the starting amounts of the samples, the individual
peak areas of each iTRAQ signature peak were log transformed
to yield a normal distribution and normalized to the mean peak
area of every sample. Protein abundances in every experiment
were determined by taking the average normalized standardized
iTRAQ peak area of all unique peptides annotated to a protein.
Finally, the standardized protein means (four mutant and four
wildtype in each experiment) were used to calculate the average
difference between wildtype and mutant mice. To assess
whether differences had occurred by chance or could be
deemed significant, we calculated permutation-derived false
discovery rates (FDR), using Significance Analysis of Micro-
arrays (SAM)30 as implemented in the Multi Experiment
Viewer software (MeV, version 4.6.1).30,31 Conventional t-tests
or fold change alone do not take into account the effect of
multiple testing and tend to overestimate the number of
differentially regulated proteins. SAM on the other hand is a
data resampling-based method and creates randomized data
distributions in order to estimate false positive rates.30 In
contrast to conventional multiple testing correction methods,
SAM is more adaptive to different biological experiments that
may have asymmetrical distribution of differential protein
expression profiles. It was previously demonstrated that SAM
can be successfully applied to proteomics data.32−36 The SAM
q-values reflect for each protein the number of empirically
determined false-positives at the significance level of the
respective protein. The false discovery rate (FDR) levels in our
results thus hold information about individual proteins and
should not be interpreted as a global FDR. Changes in protein
expression are considered to be significant when the FDR is
<10%.
Functional Protein Group Analysis
All quantified proteins were assigned to one of 17 functional
synaptic protein groups as previously defined.37,38 Up- and
downregulated proteins at each time point (P28 and P112)
were separately tested for overrepresentation of functional
protein groups using a Fisher’s exact test.
Immunoblotting
Western blot analysis was performed on six independent
synaptosome protein extracts, i.e., the four samples that were
used in the iTRAQ experiment plus two independent samples
derived from two animals each. Of each sample, 2.5 μg protein
was mixed with SDS sample buffer and heated to 90 °C for 5
min. Proteins were separated on a Criterion XT Precast Gel
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(4−12% Bis-Tris; Bio-Rad) in a Criterion Cell Electrophoresis
System (Bio-Rad) and electroblotted onto PVDF membrane
overnight at 4 °C. After blocking with 5% nonfat dry milk in
TBS-T (TBS plus 0.5% Tween) for 1 h, blots were incubated
with primary antibodies, followed by an alkaline phosphatase-
conjugated secondary antibody (Dako, Glostrup, Denmark;
1:10,000). The following antibodies were used: anti-PSD95
(NeuroMab, Davis, CA, USA; 1:5,000), anti-UQCRC2
(Abcam; 1:500), anti-GAP43 (GenScript, New Jersey, NJ,
USA; 1:2,000), anti-NCAM (Hybrdoma Bank, Iowa City, IA,
USA; 1:2,000), anti-ATP1B2 (GenScript; 1:2,000), anti-
CamKIIa (GenScript; 1:1,000), and anti-GluA1 (GenScript;
1:1,000). Blots were incubated with ECF substrate (GE
Healthcare, Pollards Wood, U.K.), scanned with a FLA 5000
instrument (Fujifilm) and analyzed with Quantity One software
(Bio-Rad) using background correction. To correct for
differences in sample input, half of the same gel was stained
with Coomassie blue and scanned, and the densitometric values
were used for normalization.28,36 Significance was determined
using a Student’s t-test (1-tailed, independent samples).
■ RESULTS
Ercc1−/− Hippocampal Neurons Display Normal Outgrowth
and Synapse Formation in Vitro
Ercc1 mutant mice are normal at birth but soon develop a
severe and accelerated aging phenotype. To investigate whether
neurons in the central nervous system are normal at birth and
are not functionally impaired due to their inability to repair
DNA during embryonic development, we isolated E18 primary
hippocampal neurons from Ercc1−/− mice and tested whether
these neurons are capable of normal dendrite outgrowth and
synapse formation in vitro compared to wildtype neurons.
Neurons were cultured, fixed at DIV6, DIV9, DIV12, and
DIV15, and co-stained with a nuclear marker (Hoechst), a
dendritic marker (MAP2), and a presynaptic vesicle marker
(VAMP) (Figure 1A). Dendrite outgrowth and synapse
formation were quantified using automated high-content
microscopy. No significant differences in dendrite outgrowth
and synapse formation were observed between Ercc1−/− and
wildtype neurons (Figure 1B), indicating that neuronal network
development of Ercc1−/− neurons proceeds normally in vitro.
Moreover, the number of neurons remained the same over
Figure 1. Ercc1−/− hippocampal neurons display normal outgrowth and synapse formation in vitro. (A) E18 primary hippocampal neurons of
Ercc1−/− (KO) mice and wildtype (WT) littermates were fixed at DIV6, DIV9, DIV12, and DIV15 and co-stained with a nuclear marker (Hoechst), a
dendritic marker (MAP2), and a presynaptic vesicle marker (VAMP). (B) Total cell numbers were stable over time. Dendrite length and the number
of synapses per dendrite increased over time, indicating maturation of the neuronal network. No differences in network development were observed
between Ercc1−/− mice and wildtype littermates.
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time, indicating that the Ercc1−/− repair defect did not cause
increased cell death under normal conditions. These findings
show that Ercc1 mutant hippocampal neurons have no apparent
developmental impairments that might account for the age-
related deficits observed postnatally. Interestingly, when
neurons were exposed to rotenone in order to inhibit
mitochondrial electron transport,39 we observed a significant
reduction in the viability of Ercc1−/− neurons compared to
wildtype neurons, suggesting impaired mitochondrial function
in Ercc1−/− neurons and increased susceptibility to oxidative
stress (data not shown).
Ercc1Δ/− Mice Have Normal Hippocampal Synapse
Densities at 16 Weeks of Age
To determine whether synapse numbers are affected in Ercc1
mutant mice in vivo, we performed immunohistochemistry on
hippocampal sections of Ercc1Δ/− and wildtype mice at P112.
We used Ercc1Δ/− mice in these and in all following
experiments, as they allow a temporal window of 16 weeks to
study age-related synaptic changes, whereas Ercc1−/− mice die
at an age of 4 weeks on average. No differences were observed
between hippocampal sections of Ercc1Δ/− mice and wildtype
control mice in the distribution or in the staining intensity of
the dendritic marker MAP2 (Figure 2A); both the dendritic
layers and the cell body layers have a normal gross
morphological appearance. In addition, we performed Golgi-
Cox staining and quantified synapses in all regions of the
hippocampus of Ercc1Δ/− mice and of wildtype controls. No
differences were observed in the density of dendritic spines in
any region of the hippocampus (Figure 2B and C). Together,
these findings show that hippocampal synapse numbers are
normal in 16-week-old Ercc1Δ/− mice and are consistent with
earlier reports showing that hippocampal morphology and cell
numbers are normal in aged Ercc1Δ/− mice.25
Ercc1Δ/− Mice Show Age-Related Changes in Hippocampal
Synapse Protein Composition
After having established normal growth, synapse formation,
synapse numbers, and connectivity of hippocampal neurons,
both in vitro and in vivo, we continued to investigate age-
dependent changes in the molecular composition of the
hippocampal synapses. Specifically, we performed 8-plex
iTRAQ proteomics of hippocampal synaptosomes isolated
from Ercc1Δ/− and wildtype littermates at 4 weeks (P28) and 16
weeks (P112) of age (Supplemental Figure S1) in order to
identify whether quantitative changes in the proteome of
hippocampal synapses may provide an explanation for the age-
related behavioral deficits in Ercc1Δ/− mice.25 We confirmed the
isolation of synaptosomes by showing enrichment of the
synaptic protein marker PSD-95 (Supplemental Figure S2). For
each time point, four independent Ercc1Δ/− samples were
compared with four independent wildtype samples. These four
samples thus provide biological replicates and allow us to
adequately test the reproducibility of our findings. All iTRAQ
data are summarized in Supplemental Tables S1 and S2. We
identified a total of 288 proteins with at least three peptides
with a confidence interval >95%, and which were quantifiable
by at least three peptides at each time point (Supplemental
Table S3). SAM analysis indicated that the levels of 175
proteins were significantly different from wildtype controls at
one or both time points (FDR <10) (Figure 3A; Supplemental
Table S4). Most significant differentially expressed proteins
were detected at P112 (148 proteins), whereas many fewer
proteins showed differential expression at P28 (77 proteins).
Fifty proteins showed significant differential expression at both
time points. Thus, impaired DNA repair impacts heavily on the
quantitative composition of the hippocampal synapses.
To confirm the iTRAQ results, we next performed
quantitative immunoblotting (n = 6 per genotype) for a
Figure 2. Ercc1Δ/− mice have normal hippocampal synapse numbers at 16 weeks of age. (A) MAP2 immunohistochemistry on hippocampal sections
revealed no differences between Ercc1Δ/− mice and wildtype control mice in the distribution or the staining intensity of the dendritic marker MAP2.
(B) Representative images of Golgi-Cox-stained sections of the hippocampal CA1 region. Spines were counted as synapses when spine heads were
clearly visible outside the dendritic shaft region (arrowheads indicates examples valid spine profiles). (C) Quantification of dendritic spine densities
in the CA1, CA3 and dentate gyrus (DG) regions of the hippocampus shows no differences between Ercc1Δ/− mice and wildtype littermates. N-
numbers represent the numbers of dendrites included in the spine counts.
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representative set of significant differentially expressed proteins
(Figure 4). For proteins that were significantly regulated at P28,
we confirmed the upregulation of neuromodulin (Gap43),
neural cell adhesion molecule 1 (Ncam1), and Na,K-ATPase
subunit beta-2 (Atp1b2) and the downregulation of calcium/
calmodulin-dependent protein kinase II subunit alpha
(Camk2a) (Figure 4A). For proteins that were significantly
regulated at P112 we confirmed the upregulation of Gap43 and
the downregulation of cytochrome b-c1 complex subunit 2
(Uqcrc2), AMPA-selective glutamate receptor subunit 1
(GluA1), and Camk2a (Figure 4B). These findings demon-
strate that there is a perfect correlation between protein
expression as measured by iTRAQ quantitative proteomics and
by quantitative immunoblotting. In most cases, the changes in
protein levels assessed by immunoblotting exceed the changes
observed by iTRAQ, a phenomenon that was previously
described in several other studies.28,33
Functional Characterization of Hippocampal Proteome
Changes in Ercc1Δ/− mice
To permit a large-scale functional interpretation of the overall
changes in synaptic protein expression in Ercc1 mutant mice,
we also selected and quantified proteins using less stringent
criteria. Instead of only including proteins with three or more
quantifiable peptides at each time point, we now included all
proteins with three or more quantifiable peptides at one time
point and at least one quantifiable peptide at the other time
point. By doing so, we reduce the risk of selectively discarding
proteins that are less abundant at one time point, resulting in
fewer detectable peptides at that time point. Using the relaxed
protein selection criteria, a 52% increase in the total number of
identifiable proteins was observed (439 compared to 288 using
stringent selection; Supplemental Table S5). SAM analysis
showed that the expression levels of 216 proteins were
significantly different from those of wildtype controls at one
or both time points (FDR <10) (Figure 3A; Table 1;
Supplemental Table S6), which is 23% more than with
stringent selection criteria. This modest increase in the number
of differentially expressed proteins, together with the relatively
strong increase in the number of detectable proteins,
significantly increases the statistical power to detect changes
in the overall expression of functional groups of protein.33
We next categorized all proteins in 17 functional synaptic
protein groups as previously defined37,38 (Figure 3B) and used
a Fisher’s exact test to determine which protein functions are
significantly enriched within each of four protein clusters, i.e.,
proteins that are upregulated at P28, proteins that are
downregulated at P28, proteins that are upregulated at P112,
Figure 3. Ercc1Δ/− mice show age-dependent changes in the proteomic composition of hippocampal synapses. (A) Bar graphs showing the number
of significantly up- (red bars) and downregulated (blue bars) proteins at P28 and P112 (mutant relative to wildtype; FDR <10). Dark red and blue
bars indicate protein numbers under stringent protein selection criteria; pale red and blue bars indicate protein numbers under relaxed protein
selection criteria (see text for details). (B) Using relaxed protein selection criteria, a total of 439 proteins were detected, which could be assigned to
17 different functional protein groups. (C) Up- and downregulated proteins at either P28 (left panel) or P112 (right panel) were differentially
enriched for several functional protein groups. Red and blue bars indicate the number of up- and downregulated proteins per functional group (dark
red/blue, stringent protein selection criteria; pale red/blue, relaxed protein selection criteria). Functional protein group names indicated in bold are
significantly enriched in the corresponding protein cluster using a Fisher’s exact test (see also Table 1).
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and proteins that are downregulated at P112 (Figure 3C; Table
2). The most significant enrichment was observed for
mitochondrial proteins in downregulated protein clusters,
both at P28 and at P112, with protein numbers increasing
from 17 at P28 to 56 at P112. In addition, three protein
functions were significantly enriched in upregulated proteins at
P28, i.e., ion balance, cell adhesion, and G-protein relay. The
latter two were also significantly enriched in upregulated
proteins at P112. Finally, we observed a significant enrichment
of proteins involved in ligand-gated ion channel (LGIC)
signaling in downregulated proteins at P112. In particular,
subunits of AMPA- and NMDA-type glutamate receptors were
significantly downregulated at this time point. It is noteworthy
that we observed a concomitant downregulation of several
glutamate receptor-scaffolding proteins (protein clustering) and
of several downstream intracellular signaling proteins. Although
these last two functional groups were not significantly enriched,
they do confirm that glutamate receptor signaling is indeed
decreased at P112, but not yet at P28. Individual protein
members of the above-mentioned functional groups (except
mitochondrial protein) are listed in Figure 5, together with
their levels of regulation at each time point. Taken together, our
data show a significant and age-dependent deregulation of
distinct synaptic protein signaling pathways during DNA
damage-induced aging.
■ DISCUSSION
Ercc1 Mutant Mice As a Model for DNA Damage Induced
Age-Related Synaptic Dysfunction
DNA damage plays an important role in aging.6 Accumulation
of DNA damage is associated with the age-dependent decline in
vital functions,40−42 and defects in genome maintenance are
associated with accelerated aging in humans.10−12 Thus, DNA
is an important target of aging, and maintenance of genome
integrity is a major anti-aging mechanism. Increasing evidence
suggests that accumulation of DNA damage and subsequent
genotoxic stress are also involved in aging of the brain43−45 and
that the inability of neurons to appropriately handle DNA
damage may be causative in the etiology of neurodegenerative
disorders.46−49 As a model for accelerated brain aging we use
Figure 4. Validation of iTRAQ results by quantitative immunoblotting. (A) For proteins that were significantly regulated at P28, we confirmed the
upregulation of neuromodulin (Gap43), neural cell adhesion molecule 1 (Ncam1), and Na,K-ATPase subunit beta-2 (Atp1b2) and the
downregulation of calcium/calmodulin-dependent protein kinase II subunit alpha (Camk2a). (B) For proteins that were significantly regulated at
P112, we confirmed the upregulation of Gap43 and the downregulation of cytochrome b-c1 complex subunit 2 (Uqcrc2), AMPA-selective glutamate
receptor subunit 1 (GluA1), and Camk2a. *FDR <10 (iTRAQ) or p < 0.05 (immunoblot).
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Ercc1 mutant mice. Ercc1 mutant mice are indistinguishable
from wildtype littermates at birth. However, they soon develop
a severe and accelerated aging phenotype,15,20−22 including
progressive age-related neuropathological changes in the brain
and the spinal cord and at neuromuscular junctions.23 In a
recent study, it was shown that hippocampal neurons in
Ercc1Δ/− mice show an age-dependent increase in the
expression of several genotoxic markers, i.e., p53 and ATF3,
compared with wildtype littermates, while very few neurons
actually experienced cell death.25 The authors conclude that
between P28 and P112, neurons in the hippocampus of
Ercc1Δ/− mice become increasingly compromised due to
genotoxic stress but do not die. Here we further substantiate
these findings by showing that in addition to being healthy,
cultured Ercc1 mutant hippocampal neurons are capable of
normal dendrite growth and synapse formation. Moreover, we
did not observe differences in the gross dendritic morphology
of the hippocampus or in the density of hippocampal dendritic
spines between Ercc1Δ/− mice and wildtype littermates at P112.
In the literature, there is still controversy whether synapse loss
actually contributes to early cognitive signs of aging.50 In the
Ercc1 mutant mouse model, however, hippocampal synapse loss
does not seem to be an important factor, allowing us to identify
molecular changes at synapses that precede, or may even occur
in the absence of, overt synapse loss.
Table 1. Selection of Proteins That Are Significantly Regulated in Hippocampal Synapses of Ercc1Δ/− Micea
log-fold change (KO/WT) SAM FDR (%) t-test p-value
protein ID gene symbol P28 P122 P28 P112 P28 P112
G-Protein Relay
GBG2_MOUSE Gng2 0.49 0.16 0.0 18.1 0.003 0.157
GNAO_MOUSE Gnao1 0.42 0.49 0.0 0.0 0.012 0.002
GBG7_MOUSE Gng7 0.31 0.23 2.0 8.8 0.042 0.129
GNAZ_MOUSE Gnaz 0.27 0.18 0.0 8.8 0.003 0.077
GNAS2_MOUSE Gnas 0.20 0.21 0.0 1.8 0.002 0.014
GNA11_MOUSE Gna11 0.20 0.05 5.5 42.2 0.060 0.579
GBB1_MOUSE Gnb1 0.20 0.15 5.5 6.9 0.058 0.023
GNAI2_MOUSE Gnai2 0.10 0.32 39.2 0.0 0.267 0.014
GNA13_MOUSE Gna13 0.14 0.22 20.4 4.5 0.182 0.049
GNAI3_MOUSE Gnai3 0.12 0.21 13.3 2.4 0.054 0.024
Ion Balance/Transport
148707687 Atp2b4 0.61 0.13 0.0 22.8 0.002 0.151
AT1B1_MOUSE Atp1b1 0.50 0.36 0.0 1.3 0.012 0.040
CXA1_MOUSE Gja1 0.38 0.60 4.4 0.0 0.117 0.000
NAC1_MOUSE Slc8a1 0.35 0.07 0.0 36.3 0.037 0.358
AT1B2_MOUSE Atp1b2 0.33 0.19 1.7 25.5 0.067 0.296
AT1A1_MOUSE Atp1a1 0.29 0.24 3.2 1.3 0.060 0.013
S12A5_MOUSE Slc12a5 0.25 0.19 6.2 2.4 0.115 0.015
AT1A3_MOUSE Atp1a3 0.23 0.37 5.5 1.1 0.090 0.027
S4A10_MOUSE Slc4a10 0.21 0.06 4.1 33.8 0.045 0.168
VPP1_MOUSE Atp6v0a1 0.16 −0.02 7.2 39.4 0.041 0.770
Cell Adhesion/Transsynaptic Signaling
NCAM1_MOUSE Ncam1 0.53 0.49 0.0 0.0 0.002 0.002
L1CAM_MOUSE L1cam 0.45 0.33 0.0 1.4 0.001 0.032
CNTN1_MOUSE Cntn1 0.37 0.32 0.0 0.0 0.007 0.016
GPM6A_MOUSE Gpm6a 0.37 0.21 1.9 15.5 0.061 0.202
CD166_MOUSE Alcam 0.36 0.39 0.0 0.0 0.001 0.018
NTRI_MOUSE Ntm 0.33 0.14 0.0 24.9 0.036 0.218
GPM6B_MOUSE Gpm6b 0.30 0.12 2.4 29.0 0.032 0.274
OX2G_MOUSE Cd200 0.28 0.27 0.0 1.4 0.001 0.016
OMGP_MOUSE Omg 0.22 0.25 3.0 1.3 0.033 0.020
TENR_MOUSE Tnr 0.22 0.22 8.1 3.0 0.128 0.039
NFASC_MOUSE Nfasc 0.15 0.19 8.2 1.3 0.053 0.003
IGSF8_MOUSE Igsf8 0.15 0.23 4.1 1.1 0.005 0.005
NRX1A_MOUSE Nrxn1 0.12 −0.12 6.2 14.2 0.005 0.201
148694008 Nptn 0.09 −0.15 46.9 6.5 0.455 0.055
LGIC Signaling
GRIA2_MOUSE Gria2 0.03 −0.14 52.9 8.3 0.644 0.074
NMDE2_MOUSE Grin2b 0.07 −0.22 46.9 1.7 0.337 0.014
NMDZ1_MOUSE Grin1 −0.05 −0.26 37.3 0.8 0.558 0.012
GRIA1_MOUSE Gria1 −0.08 −0.26 33.3 1.7 0.436 0.028
NMDE1_MOUSE Grin2a 0.08 −0.27 46.9 0.0 0.419 0.000
aProteins that are involved in G-protein relay, ion balance, cell adhesion, and LGIC signaling and that are significantly regulated at one or both time
points (using relaxed protein selection criteria) are listed, together with their associated log-fold change, FDR percentage, and p-value.
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Robust and Dynamic Changes in Synaptic Proteome
Composition of Ercc1 Mutant Mice
Quantitative proteomics revealed that the hippocampal synaptic
proteome of Ercc1Δ/− mice is very different from that of
wildtype littermates. Depending on whether stringent or
relaxed protein inclusion criteria were applied, 49−61% of all
detected proteins showed significantly changed levels. These
findings indicate that defective DNA repair as a result of the
Ercc1 mutation has a relatively large impact on synaptic protein
composition.
Many changes in synaptic protein levels are age-specific, and
we observed little overlap in significantly deregulated proteins
at the two different time points that we investigated. Most
changes in synaptic protein levels were observed at P112. This
corresponds with the age at which Ercc1Δ/− mice start to show
reduced hippocampal long-term potentiation as well as clear
deficits in spatial learning and memory.25 Changes in synaptic
protein levels at P112 may thus directly underlie physiological
and behavioral alterations that are linked to age-related
cognitive decline. At P28, on the other hand, no alterations
in hippocampal synaptic plasticity and learning behavior are yet
apparent.25 Still, many synaptic proteins show significant
changes in abundance at P28, and these changes are often
specific for this early time point. It is tempting to speculate that
these changes precede any significant physiological or
behavioral deficits and that they thus may reflect early causative
mechanisms in age-related cognitive decline (see below).
Early Proteomic Changes in Ercc1 Mutant Synapses:
Causative Factors for Cognitive Decline?
Synaptic proteins that are early affected in Ercc1 mutant mice
may play a causal role in the cognitive impairment observed
later. Overrepresentation analysis of protein clusters that are
either up- or downregulated at P28 revealed an enrichment of
four distinct functional protein groups. Mitochondrial proteins
were significantly enriched in downregulated proteins at P28.
Mitochondrial dysfunction and the progressive decline in
mitochondrial gene expression are conserved features of
aging.51,52 Moreover, age-related or toxin-induced mitochon-
drial dysfunction underlies neurodegenerative disorders, and it
has been proposed that ROS-mediated mitochondrial defects
may accumulate during and contribute to disease progression.53
Finally, there is a causal and self-reinforcing link between
mitochondrial dysfunction, ROS production, and DNA
damage,54 which may explain the lower synaptic expression of
mitochondrial proteins in Ercc1 mutant mice. Although on the
basis of our proteomics data we cannot distinguish between
differences in mitochondrial protein levels and overall
mitochondrial abundance, our findings do confirm an
important role for synaptic mitochondria during the early
stages of brain aging.
Among upregulated proteins at P28, we observed a
significant enrichment of proteins associated with ion balance.
In particular, we found all subunits of the Na,K-ATPase
complex to be more abundant in Ercc1 mutant mice. Na,K-
ATPase is a membrane-embedded sodium pump that functions
to maintain the asymmetric distribution of sodium and
potassium across the plasma membrane.55 Sodium gradients
form the foundation for synaptic transmission and neuronal
excitation, and changes in the levels of Na,K-ATPases can cause
long-term alterations in synaptic transmission.56 Na,K-ATPases
are also the primary energy consumers in the brain, utilizing
half of the brains ATP content. Na,K-ATPases will therefore be
Table 2. Significantly Enriched Functional Protein Classes
within Protein Expression Clustersa
functional
group
present in all detected
proteins
present in
cluster
Fisher’s exact
p-value
P28 Up
cell adhesion 439/23 68/13 0.0003
G-protein relay 439/11 68/7 0.0054
ion balance 439/26 68/10 0.0184
P28 Down
mitochondria 439/114 24/17 <0.0001
P112 Up
cell adhesion 439/23 72/9 0.0312
G-protein relay 439/11 72/8 0.0022
P112 Down
mitochondria 439/114 103/56 <0.0001
LGIC signaling 439/6 103/5 0.0397
aAll quantified proteins were assigned to one of 17 functional synaptic
protein groups. Up- and downregulated proteins at each time point
(P28 and P112) were separately tested for overrepresentation of
functional protein groups using a Fisher’s exact test. Numerators
represent the total number of proteins detected; denominators
represent the number of proteins belonging to the indicated functional
class.
Figure 5. List of proteins that are significantly regulated in
hippocampal synapses of Ercc1Δ/− mice. Proteins that belong to the
functional protein groups cell adhesion (A), ion balance (B), G-
protein relay (C), LGIC signaling (D), protein clustering (E) and
intracellular signaling (F) and that are significantly regulated at one or
both time points (relaxed protein selection criteria) are indicated,
together with their levels of regulation. Red indicates proteins that are
upregulated; blue indicates proteins that are downregulated (mutant
relative to wildtype).
Journal of Proteome Research Article
dx.doi.org/10.1021/pr201203m | J. Proteome Res. 2012, 11, 1855−18671863
affected by decreased concentrations of ATP, caused by
mitochondrial dysfunction, and the higher levels of Na,K-
ATPases that we observed might be a compensatory
mechanism to counteract the consequences of ATP depletion.
We also found a significant enrichment of proteins involved in
G-protein relay and in cell adhesion, both associated with
upregulated proteins at P28. G-proteins are central relay factors
between the activation of plasma membrane receptors by
extracellular ligands, and the cellular responses that these
ligands induce. In a recent large-scale gene linkage study,
synaptic G-proteins were demonstrated to be significantly
associated with cognitive ability (IQ).37 In addition, several G-
protein pathways have been implicated in the pathology of
Alzheimer’s disease.57 Thus, early deregulation of synaptic G-
proteins may well be an important contributing factor to age-
dependent cognitive decline. Cell adhesion molecules may
serve to facilitate both the organization and adhesion of the
synapse. Dysfunction of cell adhesion molecules can lead to
abnormalities in cell migration and synaptic plasticity and are
found to be causal to cognitive impairments observed in, for
instance, autism58,59 and schizophrenia.60,61 Whether early
deregulation of these molecules also underlies age-dependent
cognitive decline needs to be determined.
Late Proteomic Changes in Ercc1 Mutant Synapses:
Pathways for Permanent Cognitive Dysfunction?
Late affected synaptic proteins are more likely to be involved in
the actual physiological changes underlying synaptic dysfunc-
tion and cognitive decline. Similarly as for P28, we observed a
significant enrichment of mitochondrial proteins among
downregulated proteins at P112 and of proteins involved in
G-protein relay and in cell adhesion among upregulated
proteins at P112, indicating that these represent sustained
synaptic proteome changes in Ercc1 mutant mice. A significant
and age-specific enrichment was observed for proteins involved
in LGIC signaling among downregulated proteins at P112.
Interestingly, all five proteins in this functional group are
ionotropic glutamate receptors, including the two major
AMPA-type receptor subunits Gria1 and Gria2, which mediate
fast excitatory transmission at hippocampal synapses, and the
major NMDA-type receptor subunits Grin1, Grin2a, and
Grin2b, which mediate calcium influx required for long-term
changes in synaptic strength and are key to hippocampal
learning and memory.62 Interestingly, a concomitant down-
regulation of several proteins involved in protein clustering and
intracellular signaling was observed. Although these functional
protein groups were not significantly enriched using a Fisher’s
exact test, their individual protein members all show a
significant downregulation in Ercc1 mutant synapses at P112
specifically. Downregulated clustering proteins include Dlg2
(PSD-93), Dlg3 (SAP102), Dlg4 (Psd-95), Dlgap3, and
Shank3, which are postsynaptic density proteins involved in
the scaffolding of AMPA- and NMDA-type glutamate
receptors.63 Reduced abundance of these proteins in Ercc1
mutant synapses at P112 thus reflects the inability of these
synapses to correctly organize postsynaptic glutamate receptor
signaling. Downregulated intracellular signaling proteins
include three subunits of the calcium/calmodulin-dependent
protein kinase type II complex (Camk2a, Camk2b, and
Camk2g), both subunits of the calcium-dependent protein
phosphatase calcineurin (Ppp3ca and Ppp3r1), and the
calcium-binding protein Hpca (hippocalcin). These proteins
all mediated calcium-dependent signaling downstream of
NMDA receptors64 and thus reflect reduced plasticity signaling
in Ercc1 mutant hippocampal glutamatergic synapses at P112.
Importantly, Camk2 activation is regarded a master-switch for
the induction of synaptic plasticity underlying learning and
memory.65
Reduced expression of synaptic glutamate receptors and of
synaptic glutamate receptor scaffolding and signaling compo-
nents in Ercc1Δ/− mice at P112 may well explain the deficits in
hippocampal synaptic plasticity and learning behavior observed
at this age.25 These late changes in synaptic protein levels may
however result from earlier changes, and establishing such
causal relationships is important for defining molecular targets
that may be used to pharmacologically treat and prevent
Figure 6. Synaptic proteins and cognitive decline: a hypothetical
model. On the basis of our findings we propose the following model to
explain DNA damage-induced aging and cognitive decline. Compro-
mised DNA damage repair as in Ercc1 mutants causes mitochondrial
dysfunction. This then leads to increased levels of reactive oxygen
species (ROS), which in turn causes further DNA damage and
mitochondrial dysfunction. This self-reinforcing cycle of detrimental
decline is central to normal and pathological aging.54 Reduced
mitochondrial activity or abundance also results in lowered
concentrations of ATP, which in turn affects Na,K-ATPase function.
The up-regulation of Na,K-ATPases that we observed could be a
compensatory mechanism to counteract the effect of ATP depletion.
Dysfunction of Na,K-ATPases is known to induce a rapid reduction in
synaptic AMPA receptor surface expression and AMPA receptor
protein abundance, leading to a long-lasting changes in synaptic
function.56 In addition to Na,K-ATPases, we found an early
upregulation of proteins associated with G-protein relay and cell
adhesion. Together, these early changes may lead to synaptic
dysfunction and cognitive decline later in life.
Journal of Proteome Research Article
dx.doi.org/10.1021/pr201203m | J. Proteome Res. 2012, 11, 1855−18671864
cognitive decline. In this respect it is interesting to note that
Na,K-ATPase deregulation, as we observed at P28, is causally
linked with glutamate receptor surface expression.56 Na,K-
ATPases are enriched at synapses and are co-localized and
associated with ligand-gated ion channels such as AMPA
receptors. Na,K-ATPase dysfunction induces a rapid reduction
in AMPA receptor surface expression as well as total protein
abundance, leading to a long-lasting depression of synaptic
transmission.56 As such Na,K-ATPase and mitochondrial
dysfunction may well precede and possibly cause the observed
glutamatergic signaling deficits.
■ CONCLUSIONS
A Model for Synaptic Dysfunction and Age-Related
Cognitive Decline
In conclusion, we have provided a first comprehensive systems-
level characterization of the temporal changes that occur in the
synaptic proteome in a well-defined DNA repair deficient
mouse model for aging. Our data implicate different synaptic
signaling pathways in age-related synaptic dysfunction and lead
to the following hypothetical model (Figure 6): (1) early
downregulation of mitochondria causes ATP depletion, (2)
ATP depletion leads to Na,K-ATPase dysfunction and a
compensatory upregulation of Na,K-ATPase subunit expres-
sion, (3) dysfunction of Na,K-ATPases results in progressive
downregulation of synaptic glutamate receptor expression and
signaling, which causes long-term changes in synaptic function
and cognitive impairment, and (4) other synaptic changes,
including increased levels of G-proteins and cell adhesion
proteins, may contribute to cognitive decline. Future experi-
ments are required to determine how relevant these alterations
are for human aging and, if so, whether targeted intervention of
any of these pathways is able to improve cognitive function in
aged humans.
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